Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | IMRN Immuron Limited | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.22 +3.4% | $15.06 -2.0% |
| StockIQ Score | 46D+ Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 39F | 13F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 68B- | 50C- |
| Quality | — | 50C- |
| Risk | 34F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Immuron (IMRN) outperforms Ascentage Pharma (AAPG) in nearly every category. Its investor score (73 vs. 37) and technical score (83 vs. 18) are significantly higher, while AAPG’s scores are all below 60. IMRN’s "STRONG" rating contrasts sharply with AAPG’s "WEAK," reflecting stronger overall confidence in its performance.